Skip to main content
Guest homeNews home
Story

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma - GSK

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma  GSK GSK's Exdensur approved in US as first twice-yearly asthma treatment  FirstWord Pharma GSK wins US approval for twice-yearly asthma drug  Reuters GSK rounds out year of approvals with FDA asthma nod for long-acting biologic Exdensur  Fierce Pharma GSK Wins Asthma Approval for Anti-Inflammatory Antibody  BioSpace

Latest News